After 40 self-funded years, Iswarya raises ₹350 crore from OrbiMed to expand fertility treatment across underserved India.
In 1986, when Dr.
S.
Chandralekha started what would become Iswarya Fertility Center, IVF wasn't just expensive in India, it was largely out of reach, unfamiliar, and quietly stigmatised.
Nearly forty years later, her organisation has just closed a Rs 350 crore growth round from OrbiMed Asia, one of the world's largest dedicated healthcare investors.
What makes that headline unusual isn't the number.
Iswarya Fertility Center secures over ₹350 Crore from OrbiMed Asia to expand fertility care across India and enhance services.
GVK family-backed Oval Fertility has launched its first premium IVF center in Hyderabad, leveraging advanced embryo monitoring…
Hyderabad: In an expansion of its presence in the healthcare space, GVK Group has forayed into the fertility care segment with…
This article is authored by Dr Gautam Daftary, founder, chairman & managing director, Aksigen IVF.
Explore the emotional and ethical challenges in IVF, highlighting the need for compassionate care and accessible treatment in…
Investors are now focusing on artificial intelligence (AI) startups, and unfortunately India has few credible companies in this…
